These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22292875)

  • 1. Brain natriuretic peptide-guided therapy in the inpatient management of decompensated heart failure.
    Saremi A; Gopal D; Maisel AS
    Expert Rev Cardiovasc Ther; 2012 Feb; 10(2):191-203. PubMed ID: 22292875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm.
    Bhardwaj A; Januzzi JL
    Crit Pathw Cardiol; 2009 Dec; 8(4):146-50. PubMed ID: 19952548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of natriuretic peptides in heart failure].
    Ancona R; Limongelli G; Pacileo G; Miele T; Rea A; Roselli T; Masarone D; Messina S; Palmieri R; Golia E; Iacomino M; Gala S; Calabrò P; Di Salvo G; Calabrò R
    Minerva Med; 2007 Oct; 98(5):591-602. PubMed ID: 18043566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BNP in the diagnosis and risk stratification of heart failure.
    Moe GW
    Heart Fail Monit; 2005; 4(4):116-22. PubMed ID: 16234898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is B-type natriuretic peptide-guided heart failure management cost-effective?
    Morimoto T; Hayashino Y; Shimbo T; Izumi T; Fukui T
    Int J Cardiol; 2004 Aug; 96(2):177-81. PubMed ID: 15262031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic peptide-guided heart failure management.
    Troughton R; Michael Felker G; Januzzi JL
    Eur Heart J; 2014 Jan; 35(1):16-24. PubMed ID: 24216390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical uses of brain natriuretic peptide in diagnosing and managing heart failure.
    Anderson KM
    J Am Acad Nurse Pract; 2008 Jun; 20(6):305-10. PubMed ID: 18588657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Brain natriuretic peptide].
    Tsutamoto T; Horie M
    Rinsho Byori; 2004 Aug; 52(8):655-68. PubMed ID: 15478621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptides in heart failure: pathophysiological significance, diagnostic and prognostic value.
    Ghosh N; Haddad H
    Can J Physiol Pharmacol; 2011 Aug; 89(8):587-91. PubMed ID: 21806511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide-guided heart failure therapy: A meta-analysis.
    Porapakkham P; Porapakkham P; Zimmet H; Billah B; Krum H
    Arch Intern Med; 2010 Mar; 170(6):507-14. PubMed ID: 20308637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of BNP and other emerging biomarkers in heart failure evaluation and management.
    Palazzuoli A; Caputo M; Calabrò A; Nuti R
    Minerva Cardioangiol; 2012 Apr; 60(2):183-94. PubMed ID: 22495167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results.
    Wu AH
    Am Heart J; 2006 Nov; 152(5):828-34. PubMed ID: 17070141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
    Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
    J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure.
    Fonarow GC; Horwich TB
    Rev Cardiovasc Med; 2003; 4 Suppl 4():S20-8. PubMed ID: 14564225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Better treatment of heart failure by measurements of natriuretic peptides. There are still remaining problems when it comes to the interpretation of measurement levels].
    Lindstedt G; Dahlström U; Fernlund P; Schaufelberger M; Stridsberg M
    Lakartidningen; 2001 Oct; 98(41):4444-8, 4450-2. PubMed ID: 11699251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultra-rapid measurement of brain natriuretic peptide].
    Logeart D
    Arch Mal Coeur Vaiss; 2002 Mar; 95(3):185-8. PubMed ID: 11998333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of B-type natriuretic peptide in patients with diabetes and acute decompensated heart failure.
    Aspromonte N; Feola M; Milli M; Scardovi AB; Coletta C; Carbonieri E; Giovinazzo P; Di Giacomo T; Barro S; Rosso GL; Ceci V; Milani L; Valle R
    Diabet Med; 2007 Feb; 24(2):124-30. PubMed ID: 17257273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.